Redcare Pharmacy Bundle
Who Really Owns Redcare Pharmacy?
Unraveling the Redcare Pharmacy SWOT Analysis is just the beginning. The ownership structure of any company is a crucial determinant of its future, influencing everything from strategic decisions to market positioning. Understanding who owns Redcare Pharmacy, a leading online pharmacy in Europe, is key to grasping its trajectory in a competitive landscape.
From its humble beginnings as mediapharm Arzneimittelvertriebs GmbH & Co. KG in 2001 to its current status as Redcare Pharmacy N.V., the company's evolution reflects a dynamic ownership narrative. This exploration will examine the shifts in Redcare ownership, providing insights into its operational priorities and long-term vision. Discover the key players shaping the future of this prominent pharmacy company.
Who Founded Redcare Pharmacy?
The story of Redcare Pharmacy, initially known as Shop Apotheke, began in 2001. It started as an online extension of a traditional pharmacy in Cologne, Germany. The founders aimed to digitize the family pharmacy, making healthcare products more accessible.
While specific initial ownership details aren't publicly available, co-founder Stephan Weber has been a key leader for nearly 25 years. He transitioned to the Supervisory Board in May 2025. Michael Köhler is also recognized as a co-founder and former board member. The company's evolution shows a shift from private ownership to a publicly listed entity.
Early agreements and ownership dynamics are not extensively disclosed in public records. However, the company's trajectory indicates a shift from its initial private ownership to becoming a publicly listed entity. In 2004, with the legalisation of mail-order sales for non-prescription medicines in Germany, Shop Apotheke was among the first online retailers to offer these products and pharmaceutical advice, reflecting the founders' forward-thinking approach. The company's relocation of logistics and sales to Venlo, Netherlands, in 2010, and subsequent international expansion starting in 2012, further shaped its early growth and, presumably, its ownership structure through various investment phases.
Key Aspects of Redcare Pharmacy's Foundation
The founders of Redcare Pharmacy, originally Shop Apotheke, launched the company in 2001. Their goal was to bring the family pharmacy business online. The company's early growth was significantly influenced by the legalization of mail-order sales for non-prescription medicines in Germany in 2004.
- Who founded Redcare Pharmacy: Stephan Weber and Michael Köhler are key figures.
- Redcare Pharmacy company history: Started in 2001 as an online pharmacy.
- Redcare Pharmacy headquarters location: Initially in Cologne, Germany, later expanding to Venlo, Netherlands.
- Redcare Pharmacy ownership structure: Evolved from private to public ownership.
Redcare Pharmacy SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
How Has Redcare Pharmacy’s Ownership Changed Over Time?
The evolution of Redcare Pharmacy's ownership structure has been marked by key events since its initial public offering (IPO) in 2016 on the Frankfurt Stock Exchange, where it became part of the SDAX. This transition to public trading significantly altered the shareholder base, introducing a mix of retail and institutional investors. The company's journey reflects its growth and increasing appeal within the online pharmacy sector, attracting significant investment and strategic partnerships.
A pivotal development was the strategic partnership with Galenica AG, which included establishing a joint venture with Mediservice. This move, as of July 2024, saw Galenica AG increase its stake to 10%, up from 7.9% in May 2023. This partnership bolstered Redcare Pharmacy's presence in the Swiss market, influencing its ownership landscape and strategic direction. These changes highlight the dynamic nature of Redcare's ownership, driven by market dynamics and strategic alliances.
| Shareholder Category | Percentage of Shares (as of December 2024) | Notes |
|---|---|---|
| Retail Investors | 34% | Largest shareholder group. |
| Institutional Investors | 32% | Significant influence on strategic decisions. |
| Individual Insiders | 13.4% | Includes key personnel. |
| Private Companies | 7.23% | Holding a substantial percentage. |
| Public Companies | 9.98% | Reflects broader market participation. |
As of June 2025, the total shares outstanding stood at 20,024,256. Key institutional investors include JP Morgan Chase & Co. (6.1%), Smallcap World Fund Inc. (5.5%), and UBS Group AG (5.1%). Other significant shareholders are DWS Investment GmbH (4.9%), Goldman Sachs Group Inc. (3.4%), BlackRock Inc. (3.0%), and Allianz Global Investors GmbH (3.0%). Michael Köhler (7.2%) and Capital Research & Manag. (5.0%) also hold major stakes. These shifts in ownership structure highlight the company's growth and increasing appeal to institutional investors. For more details about the company's business model, you can read about it in Revenue Streams & Business Model of Redcare Pharmacy.
Key Takeaways on Redcare Ownership
The ownership of Redcare Pharmacy is diverse, with retail and institutional investors holding the largest shares.
- Galenica AG's increased stake highlights a strategic partnership.
- Institutional investors like JP Morgan Chase & Co. and BlackRock Inc. have significant holdings.
- The company's structure is influenced by its public listing and strategic alliances.
- The company's total shares outstanding as of June 2025 are 20,024,256.
Redcare Pharmacy PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
Who Sits on Redcare Pharmacy’s Board?
The current Supervisory Board of Redcare Pharmacy includes Björn Söder, who serves as Chairman, and Jaska de Bakker as Deputy Chairwoman. In May 2025, the co-founders Michael Köhler and Stephan Weber were nominated to join the Supervisory Board. This move followed the succession of Frank Köhler and Henriette Peucker. Jérôme Cochet was also proposed for re-appointment for a one-year term.
Stephan Weber's transition to the Supervisory Board is noteworthy, given his nearly 25 years in the leadership team. His extensive experience in pharma retail brings an entrepreneurial spirit to the board.
| Board Member | Role | Details |
|---|---|---|
| Björn Söder | Chairman | Current Chairman of the Supervisory Board. |
| Jaska de Bakker | Deputy Chairwoman | Current Deputy Chairwoman. |
| Michael Köhler | Supervisory Board Member | Co-founder nominated to join in May 2025. |
| Stephan Weber | Supervisory Board Member | Co-founder nominated to join in May 2025. |
| Jérôme Cochet | Supervisory Board Member | Proposed for re-appointment for a one-year term. |
The voting structure for Redcare Pharmacy generally operates on a one-share-one-vote basis. As of December 31, 2023, there were 20,203,286 ordinary bearer shares with voting rights. The top 12 shareholders collectively hold 51% ownership, indicating that no single shareholder has a majority. Retail investors hold a significant 34% stake, suggesting a broad base of public shareholder influence.
Ownership Structure of Redcare Pharmacy
The ownership structure of Redcare Pharmacy is designed to balance the interests of various stakeholders, with no single entity holding a controlling stake. The presence of a diverse shareholder base and board representation helps to ensure that decisions are made with consideration for the company's long-term health and the interests of all involved.
- One-share-one-vote voting structure.
- Top 12 shareholders hold 51% ownership.
- Retail investors hold 34% of the shares.
- No shares with special control rights.
Redcare Pharmacy Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
What Recent Changes Have Shaped Redcare Pharmacy’s Ownership Landscape?
Over the past few years, the ownership landscape of Redcare Pharmacy has seen several significant shifts. In April 2025, the company managed a placement of EUR 300 million in convertible bonds and repurchased a portion of its outstanding EUR 225 million 0.00% convertible bonds due in 2028. As of June 4, 2025, the buyback yield for Redcare Pharmacy NV was at -0.15%, and its share buyback ratio stood at -0.40% as of June 8, 2025. These financial maneuvers demonstrate active management of the company's capital structure.
A key strategic move was the acquisition of MediService AG in Switzerland, which bolstered Redcare Pharmacy's market position. This acquisition also led to Galenica AG increasing its stake to 10% in July 2024, solidifying their partnership. Leadership changes also played a role, with two board members departing in April 2024 and internal successors taking their places, indicating a stable organizational setup. The Annual General Meeting in May 2025 approved all agenda items, including the nomination of Michael Köhler and Stephan Weber to the Supervisory Board, who are co-founders and former board members.
| Metric | Value | Date |
|---|---|---|
| Institutional Ownership | 32% | December 2024 |
| Active Customer Base Increase | 1.7 million | 2024 |
| Total Sales Growth (Expected) | in excess of 25% | 2025 |
| Adjusted EBITDA Margin (Expected) | 2% to 2.5% | 2025 |
Industry trends show a rise in institutional ownership of Redcare Pharmacy, with institutions holding 32% of the company as of December 2024. The company's active customer base grew by 1.7 million to reach 12.5 million in 2024. For the full year 2025, Redcare Pharmacy anticipates total sales growth exceeding 25% and an adjusted EBITDA margin between 2% and 2.5%. These figures highlight the company's focus on growth and profitability, which may further influence Redcare ownership as it continues to expand its market presence, especially with the increasing adoption of e-Rx in Germany.
Ownership Structure
Understanding the ownership structure of Redcare Pharmacy provides insights into its strategic direction and financial health. The presence of institutional investors and key partnerships influences the company's decisions and growth trajectory.
Key Developments
Recent developments, such as acquisitions and bond placements, shape Redcare's financial position. These moves impact the company's ability to compete and expand within the online pharmacy sector.
Market Position
Redcare Pharmacy's market position is strengthened by strategic acquisitions and partnerships. These actions are critical for enhancing its competitive edge in the online pharmacy market.
Future Outlook
With projected sales growth and EBITDA margins, Redcare Pharmacy is positioned for continued expansion. This growth is expected to influence the company's ownership dynamics and market leadership.
Redcare Pharmacy Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
Related Blogs
- What are Mission Vision & Core Values of Redcare Pharmacy Company?
- What is Competitive Landscape of Redcare Pharmacy Company?
- What is Growth Strategy and Future Prospects of Redcare Pharmacy Company?
- How Does Redcare Pharmacy Company Work?
- What is Sales and Marketing Strategy of Redcare Pharmacy Company?
- What is Brief History of Redcare Pharmacy Company?
- What is Customer Demographics and Target Market of Redcare Pharmacy Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.